255 related articles for article (PubMed ID: 31296736)
1. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands.
Di Luccia B; Gilfillan S; Cella M; Colonna M; Huang SC
J Exp Med; 2019 Oct; 216(10):2231-2241. PubMed ID: 31296736
[TBL] [Abstract][Full Text] [Related]
2. Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis.
Wang B; Lim JH; Kajikawa T; Li X; Vallance BA; Moutsopoulos NM; Chavakis T; Hajishengallis G
Cell Rep; 2019 Feb; 26(6):1614-1626.e5. PubMed ID: 30726742
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis.
Backert I; Koralov SB; Wirtz S; Kitowski V; Billmeier U; Martini E; Hofmann K; Hildner K; Wittkopf N; Brecht K; Waldner M; Rajewsky K; Neurath MF; Becker C; Neufert C
J Immunol; 2014 Oct; 193(7):3779-91. PubMed ID: 25187663
[TBL] [Abstract][Full Text] [Related]
4. Citrobacter rodentium Induces Tissue-Resident Memory CD4
Bishu S; Hou G; El Zaatari M; Bishu SR; Popke D; Zhang M; Grasberger H; Zou W; Stidham RW; Higgins PDR; Spence JR; Kamada N; Kao JY
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31061145
[TBL] [Abstract][Full Text] [Related]
5. Ornithine decarboxylase supports ILC3 responses in infectious and autoimmune colitis through positive regulation of IL-22 transcription.
Peng V; Cao S; Trsan T; Bando JK; Avila-Pacheco J; Cleveland JL; Clish C; Xavier RJ; Colonna M
Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2214900119. PubMed ID: 36279426
[TBL] [Abstract][Full Text] [Related]
6. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.
Guo X; Qiu J; Tu T; Yang X; Deng L; Anders RA; Zhou L; Fu YX
Immunity; 2014 Jan; 40(1):25-39. PubMed ID: 24412612
[TBL] [Abstract][Full Text] [Related]
7. Trained ILC3 responses promote intestinal defense.
Serafini N; Jarade A; Surace L; Goncalves P; Sismeiro O; Varet H; Legendre R; Coppee JY; Disson O; Durum SK; Frankel G; Di Santo JP
Science; 2022 Feb; 375(6583):859-863. PubMed ID: 35201883
[TBL] [Abstract][Full Text] [Related]
8. IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis.
Valle-Noguera A; Sancho-Temiño L; Castillo-González R; Villa-Gómez C; Gomez-Sánchez MJ; Ochoa-Ramos A; Yagüe-Fernández P; Soler Palacios B; Zorita V; Raposo-Ponce B; González-Granado JM; Aragonés J; Cruz-Adalia A
Cell Rep; 2023 Dec; 42(12):113508. PubMed ID: 38019650
[TBL] [Abstract][Full Text] [Related]
9. Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zinc finger transcription factor Ikaros.
Heller JJ; Schjerven H; Li S; Lee A; Qiu J; Chen ZM; Smale ST; Zhou L
J Immunol; 2014 Oct; 193(8):3934-46. PubMed ID: 25194055
[TBL] [Abstract][Full Text] [Related]
10. Gata3 drives development of RORγt+ group 3 innate lymphoid cells.
Serafini N; Klein Wolterink RG; Satoh-Takayama N; Xu W; Vosshenrich CA; Hendriks RW; Di Santo JP
J Exp Med; 2014 Feb; 211(2):199-208. PubMed ID: 24419270
[TBL] [Abstract][Full Text] [Related]
11. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria.
Basu R; O'Quinn DB; Silberger DJ; Schoeb TR; Fouser L; Ouyang W; Hatton RD; Weaver CT
Immunity; 2012 Dec; 37(6):1061-75. PubMed ID: 23200827
[TBL] [Abstract][Full Text] [Related]
12. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
13. Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.
Withers DR; Hepworth MR; Wang X; Mackley EC; Halford EE; Dutton EE; Marriott CL; Brucklacher-Waldert V; Veldhoen M; Kelsen J; Baldassano RN; Sonnenberg GF
Nat Med; 2016 Mar; 22(3):319-23. PubMed ID: 26878233
[TBL] [Abstract][Full Text] [Related]
14. Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota.
Guo X; Liang Y; Zhang Y; Lasorella A; Kee BL; Fu YX
Immunity; 2015 Apr; 42(4):731-43. PubMed ID: 25902484
[TBL] [Abstract][Full Text] [Related]
15. Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease.
Li L; Shi QG; Lin F; Liang YG; Sun LJ; Mu JS; Wang YG; Su HB; Xu B; Ji CC; Huang HH; Li K; Wang HF
Mol Med Rep; 2014 Mar; 9(3):831-6. PubMed ID: 24430732
[TBL] [Abstract][Full Text] [Related]
16. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
17. Increased ILC3s associated with higher levels of IL-1β aggravates inflammatory arthritis in mice lacking phagocytic NADPH oxidase.
Chan TY; Yen CL; Huang YF; Lo PC; Nigrovic PA; Cheng CY; Wang WZ; Wu SY; Shieh CC
Eur J Immunol; 2019 Nov; 49(11):2063-2073. PubMed ID: 31350760
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide promotes host defense against enteric pathogens by modulating the recruitment of group 3 innate lymphoid cells.
Yu HB; Yang H; Allaire JM; Ma C; Graef FA; Mortha A; Liang Q; Bosman ES; Reid GS; Waschek JA; Osborne LC; Sokol H; Vallance BA; Jacobson K
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34625492
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Is Required for ILC3 Derived IL-22 and Protection From
Lin YD; Arora J; Diehl K; Bora SA; Cantorna MT
Front Immunol; 2019; 10():1. PubMed ID: 30723466
[No Abstract] [Full Text] [Related]
20. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
